{
    "eid": "2-s2.0-85058772752",
    "title": "Clinical and laboratory diagnosis of TTP: An integrated approach",
    "cover-date": "2018-11-30",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Thita Chiasakul",
        "Adam Cuker"
    ],
    "citedby-count": 60,
    "ref-count": 43,
    "ref-list": [
        "Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies",
        "Thrombotic thrombocytopenic purpura: Diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015",
        "Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): A cross-sectional analysis of the French national registry for thrombotic microangiopathy",
        "Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan",
        "Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: Comparison of incidence, demographic and clinical features",
        "Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: The experience of the Harvard TMA Research Collaborative",
        "Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: Findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry",
        "A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study",
        "Registry of 919 patients with thrombotic microangiopathies across Japan: Database of Nara Medical University during 1998-2008",
        "Survival and relapse in patients with thrombotic thrombocytopenic purpura",
        "Thrombotic thrombocytopenic purpura",
        "Regional UK TTP registry: Correlation with laboratory ADAMTS 13 analysis and clinical features",
        "Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura",
        "No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University Registry",
        "Morphologic diagnosis of thrombotic thrombocytopenic purpura",
        "Laboratory measurement of schistocytes",
        "ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes",
        "Thrombotic thrombocytopenic purpura without schistocytes on the peripheral blood smear",
        "Acute pancreatitis-induced thrombotic thrombocytopenic purpura with recurrent acute pancreatitis",
        "Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency",
        "The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange",
        "Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: The French TMA reference center experience",
        "Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: A cohort study",
        "Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort",
        "External validation of the PLASMIC score: A clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment",
        "ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: A cost-effective analysis",
        "Clinical Scoring Systems in Thrombotic Microangiopathies",
        "Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: Comparison with other assay methods",
        "Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies",
        "FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients",
        "The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: Results from the UK TTP Registry",
        "Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: Diagnostic relevance in patients suffering from acute thrombotic microangiopathies",
        "An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura",
        "Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: In vitro inhibition of ADAMTS13 activity by hemoglobin",
        "Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies",
        "Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura",
        "Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement",
        "Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20",
        "Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura",
        "Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)",
        "Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura",
        "ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases",
        "An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60003711",
            "affilname": "University of Pennsylvania Perelman School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003711",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Bioverativ",
        "Pfizer",
        "Alexion",
        "Bayer",
        "Novo Nordisk",
        "Shire"
    ]
}